Clinical trial
Safety and Efficacy of TCD-10023 (Ultimaster) Drug-eluting Stent in Management of Patients With Acute ST-Elevation Myocardial InfaRction - MASTER Study
NCT02828683 is registered in ClinicalTrials.gov with Terumo Europe N.V. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of TCD-10023 (Ultimaster) Drug-eluting Stent in Management of Patients With Acute ST-Elevation Myocardial InfaRction - MASTER Study
- Lead sponsor
- Terumo Europe N.V.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2013
- Completion date
- May 31, 2018
- Enrollment
- 500 (estimated)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
acute st segment elevation myocardial infarction